The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review
Journal of Thoracic Disease · 2024-12 · 16 (12) · 8815-8822
DOI: 10.21037/jtd-24-245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thoracic Disease, 2024-12. Verfasst von Emily June Zolfaghari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yale University School of Medicine, Yale University, New Haven, CT, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Yale University School of Medicine, Yale University, New Haven, CT, USA.
ORCID-Profile: Gavitt A Woodard
Förderung
- NCI NIH HHS
Zitieren
APA
Zolfaghari, E. J., Dhanasopon, A., & Woodard, G. A. (2024). The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review. Journal of Thoracic Disease, 16(12), 8815-8822. https://doi.org/10.21037/jtd-24-245
Vancouver
Zolfaghari EJ, Dhanasopon A, Woodard GA. The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review. Journal of Thoracic Disease. 2024;16(12):8815-8822. doi:10.21037/jtd-24-245
BibTeX
@article{Zolfaghari2024,
author = {Zolfaghari, Emily June and Dhanasopon, Andrew and Woodard, Gavitt A},
title = {The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review},
journal = {Journal of Thoracic Disease},
year = {2024},
volume = {16},
number = {12},
pages = {8815--8822},
doi = {10.21037/jtd-24-245}
}
EUVIMED